The Virtus Terranova U.S. Quality Momentum ETF (JOET) has consistently underperformed compared to the benchmark IVV since early 2020, with a negative active return of -3.99% from December 2020 to April 2026. Despite its focus on stocks with strong profitability ratings and high return on equity, its inability to provide growth-at-a-reasonable-price (GARP) exposure and disappointing performance have led the analyst to maintain a Hold rating. This ongoing underperformance questions the effectiveness of JOET's combined momentum and quality investment approach in generating alpha for investors.
Parex Resources is expected to significantly increase its production soon, yet the stock has not attracted much market attention. Historically, stocks like Parex only gain widespread interest after substantial price increases, suggesting current low ...
The Bill Gates Foundation has invested 63% of its stock portfolio in just three large-cap companies. This high concentration indicates a focused investment strategy, which could mean higher risk if those stocks underperform but also potential for sig...
Injective (INJ) surged 14.4% to $6.3, reaching a six-month high driven by increased speculative demand and short position liquidations totaling over $441k. The altcoin's market cap rose 12% to $628 million, supported by rising open interest and deriv...
Stellar (XLM) surged 38.94% to $0.2731, driven by growing interest in its blockchain technology focused on cross-border transactions and financial inclusion. Its market cap reached $9.15 billion, reflecting increased influence in the crypto market. O...
Kahn Swick & Foti, LLC is investigating Humana Inc. following the company's 2023 financial results, which revealed a higher benefits expense ratio and a significant drop in adjusted earnings per share (EPS) compared to prior forecasts. Humana reporte...
